By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sophiris Bio Inc.  

1258 Prospect Street

La Jolla  California  92037  U.S.A.
Phone: 858-777-1760 Fax: n/a


SEARCH JOBS

Sophiris Bio is a biopharmaceutical company developing PRX302, a clinical-stage, targeted therapy for the treatment of urological diseases.

YEAR FOUNDED:

May 2003

LEADERSHIP:

CEO: Randall Woods

CFO: Peter Slover

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@sophirisbio.com
Ownership: Public

Web Site: Sophiris Bio
Employees:
Symbol: SPHS
 



Industry
Pharmaceutical






Company News
Sophiris Bio (SPHS) Added To Russell Microcap Index 6/26/2017 7:52:21 AM
Sophiris Bio (SPHS) Announces That The First Patient Has Been Dosed In Phase IIb Study Of Topsalysin In Patients With Clinically Significant Localized Prostate Cancer 6/8/2017 6:23:27 AM
Sophiris Bio (SPHS) Provides Update On Phase llb Study Of Topsalysin In Localized Prostate Cancer 5/24/2017 6:20:26 AM
Sophiris Bio (SPHS) Reports First Quarter Financial Results And Key Corporate Highlights 5/16/2017 10:55:36 AM
Sophiris Bio (SPHS) Reports Fourth Quarter And Full Year 2016 Financial Results And Key Corporate Highlights 3/27/2017 1:46:09 PM
Sophiris Bio (SPHS) Reports Third Quarter 2016 Financial Results And Key Business Highlights 11/10/2016 4:42:43 PM
Sophiris Bio (SPHS) To Present At The 2016 BIO Investor Forum 10/11/2016 8:50:25 AM
5 Biotechs Under $10 With Massive Potential 9/6/2016 6:19:02 AM
Sophiris Bio (SPHS) Closes Underwritten Public Offering 8/29/2016 8:52:07 AM
Sophiris Bio (SPHS) Prices Public Offering Of Common Shares And Warrants 8/23/2016 7:31:27 AM
1234567
//-->